Blueshift Asset Management, LLC Royalty Pharma PLC Transaction History

Blueshift Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $223,686 - $250,441	5,609 New	5,609 $225,000
Q4 2021 Feb 11, 2022	SELL	$35.17 - $42.48 $440,820 - $532,444	-12,534 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$36.14 - $42.24 $1.16 Million - $1.36 Million	-32,178 Reduced 71.97%	12,534 $453,000
Q2 2021 Aug 13, 2021	BUY	$39.85 - $46.63 $1.56 Million - $1.82 Million	39,084 Added 694.46%	44,712 $1.83 Million
Q1 2021 May 06, 2021	BUY	$42.34 - $52.82 $238,289 - $297,270	5,628 New	5,628 $245,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.